Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women. [Review]

MedStar author(s):
Citation: Obstetrics & Gynecology Clinics of North America. 42(4):647-57, 2015 Dec.PMID: 26598306Institution: MedStar Washington Hospital CenterDepartment: Obstetrics and Gynecology/Family PlanningForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Contraceptive Agents, Female/ad [Administration & Dosage] | *Contraceptives, Oral, Hormonal/ad [Administration & Dosage] | *Family Planning Services | *Obesity/co [Complications] | *Venous Thromboembolism/pc [Prevention & Control] | *Weight Gain/de [Drug Effects] | Adult | Contraceptive Agents, Female/ae [Adverse Effects] | Contraceptives, Oral, Hormonal/ae [Adverse Effects] | Female | Humans | Obesity/ep [Epidemiology] | Practice Guidelines as Topic | Risk Assessment | United States | Venous Thromboembolism/ci [Chemically Induced] | Venous Thromboembolism/ep [Epidemiology] | Women's HealthYear: 2015Local holdings: Available online from MWHC library: 1996 - presentISSN:
  • 0889-8545
Name of journal: Obstetrics and gynecology clinics of North AmericaAbstract: Increasing rates of obesity have become a major public health challenge. Given the added health risks that obese women have during pregnancy, preventing unwanted pregnancy is imperative. Clinicians who provide contraception must understand the efficacy, risks, and the weight changes associated with various contraceptive methods. Despite differences in the pharmacokinetics and pharmacodynamics of hormonal contraceptives in overweight and obese women, efficacy does not appear to be severely impacted. Both estrogen-containing contraceptives and obesity increase the risk of venous thromboembolism, but the absolute risk remains acceptably low in reproductive age women. Copyright (c) 2015 Elsevier Inc. All rights reserved.All authors: Kaneshiro B, Lotke PSFiscal year: 2016Digital Object Identifier: Date added to catalog: 2017-03-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 26598306 Available 26598306

Available online from MWHC library: 1996 - present

Increasing rates of obesity have become a major public health challenge. Given the added health risks that obese women have during pregnancy, preventing unwanted pregnancy is imperative. Clinicians who provide contraception must understand the efficacy, risks, and the weight changes associated with various contraceptive methods. Despite differences in the pharmacokinetics and pharmacodynamics of hormonal contraceptives in overweight and obese women, efficacy does not appear to be severely impacted. Both estrogen-containing contraceptives and obesity increase the risk of venous thromboembolism, but the absolute risk remains acceptably low in reproductive age women. Copyright (c) 2015 Elsevier Inc. All rights reserved.

English

Powered by Koha